Crown Bioscience Announces San Diego, CA Site Expansion
International Center of Excellence for oncology biomarker and inflammation translational services created
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular, and metabolic disease research, today announced the opening of a new facility in San Diego, CA. The new site will become CrownBio’s International Center of Excellence for oncology biomarker and inflammation services.
CrownBio’s presence in San Diego, CA has grown from 17 employees in 2015 to more than 70 today, with additional hiring expected. The custom-designed 32,000 sq. ft. facility provides the additional capacity required to support the growth CrownBio forecasts in its oncology biomarker and inflammation service portfolios. As part of the expansion, significant investment was also made in the latest flow cytometry, radiation and imaging technologies
In the newly created Center of Excellence, CrownBio will enhance its current translational platforms by expanding its existing service portfolio, as well as develop an additional new suite of oncology and inflammation platforms.
The fully-operational facility is designed to ensure a streamlined workflow to optimize study efficiency. Featuring a state-of-the-art ABSL-2 vivarium and laboratory housing an infectious suite and quarantine facilities, the new site hosts significant laboratory space dedicated to storing cryo-preserved cells and tissue, including the world’s largest commercially available collection of patient-derived xenograft (PDX) models.
“The establishment of our International Center of Excellence in San Diego is both an indicator of our continued growth and a commitment to our global and domestic customers,” said CrownBio COO Yangzhou Wang. “The expansion allows us to add to our talented and diverse workforce, which will in turn support the development of novel cancer therapies globally.”
A ribbon cutting ceremony will take place on Tuesday May 14th at 9:30 am PDT
About Crown Bioscience Inc.
Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
For more information visit:
Crown Bioscience Inc.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Jobindex A/S20.8.2019 08:42:29 CEST | Pressemeddelelse
2. kvartal 2019: Væksten på jobmarkedet er gået i stå
Bizagi17.7.2019 18:02:02 CEST | Press release
Bizagi goes from Stealth to Hyper Growth Delivering Digital Transformation for World Leading Brands
Erytech Pharma S.A.16.7.2019 22:02:00 CEST | Press release
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 21, 2019
WSO215.7.2019 15:02:38 CEST | Press release
WSO2 Introduces WSO2 API Microgateway 3.0 to Simplify Creating, Deploying and Securing APIs in Microservice Environments
Lubrizol15.7.2019 08:01:33 CEST | Press release
Lubrizol Acquires Bavaria Medizin Technologie GmbH
PBSC Urban Solutions13.7.2019 00:03:47 CEST | Press release
H.S.H. PRINCE ALBERT II LAUNCHES MONABIKE, MONACO’S NEW FULLY-ELECTRIC BIKE SHARE FROM PBSC URBAN SOLUTIONS
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom